Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells
- 27 November 2019
- journal article
- letter
- Published by Springer Nature in Endocrine
- Vol. 67 (2) , 496-498
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Thyroid cancerThe Lancet, 2016
- Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cellsMolecular and Cellular Endocrinology, 2016
- Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidenceOncotarget, 2016
- RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinomaDrug Development and Industrial Pharmacy, 2016
- Signaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsJournal of Clinical Medicine Research, 2016
- Quercetin-Induced Cell Death in Human Papillary Thyroid Cancer (B-CPAP) CellsJournal of Thyroid Research, 2016
- Emerging strategies for managing differentiated thyroid cancers refractory to radioiodineEndocrine, 2015
- Quercetin and Sorafenib as a Novel and Effective Couple in Programmed Cell Death Induction in Human GliomasNeurotoxicity Research, 2013
- Sunitinib Exerts Only Limited Effects on the Proliferation and Differentiation of Anaplastic Thyroid Cancer CellsThyroid®, 2012
- Basal nitric oxide release attenuates cell migration of HeLa and endothelial cellsBiochemical and Biophysical Research Communications, 2009